TeACH System Resources for Mental Health

Phase-Based Progress Estimates
Rush University Medical Center, Chicago, IL
Mental Health
TeACH System Resources - Behavioral
< 18
All Sexes
What conditions do you have?

Study Summary

The goal of this study is to use and adapt existing digital mental health technologies to advance the engagement, assessment, detection, treatment, and delivery of services for pediatric mental health. Specifically, user-centered design methodologies and an implementation science framework will be used to guide the development and implementation of the Teen Assess, Check, and Heal (TeACH) System into a pediatric primary care clinic serving teens and families from underserved communities. Study objectives include: Collaborating with underserved teens and their parents to identify strategies to target top barriers to engagement as well as top ethical concerns and requirements for cultural relevance, usability, and usefulness of the TeACH System (Phase 1) Refining the plan for implementing the TeACH System through observations, interviews, and co-design workshops with pediatric primary care pediatricians and staff (Phase 2), and Implementing the TeACH System into a primary care clinic and evaluating it in a randomized trial. (Phase 3) The team will measure engagement outcomes and satisfaction with the TeACH System.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

14 Primary · 6 Secondary · Reporting Duration: Administered to primary care staff through study completion, an average of once per year.

Administered at the one-week follow-up survey for randomized participants.
COVID-19 Exposure and Family Impact Survey (CEFIS)
Self-Stigma of Seeking Help Scale (SSOSH)
Administered immediately after initiating use of the TeACH System; teen participants complete only once.
Kiddie-Computerized Adaptive Tests (K-CAT)
Administered immediately after receiving randomized feedback/resources from TeACH System
After-Scenario Questionnaire (ASQ)
Anxiety Understanding
Confidence to Act
DMH use for Anxiety
Likelihood of using DMH for Anxiety
Administered once; immediately after receiving randomized feedback/resources
System Usability Scale (SUS)
Administered one week after interaction with TeACH System
After-Scenario Questionnaire (ASQ) Maintenance
Anxiety Understanding Maintenance
Confidence to Act Maintenance
DMH use for Anxiety Maintenance, Change in DMH Use Following TeACH System Interaction
Likelihood of using DMH for Anxiety Maintenance
Administered to primary care staff through study completion, an average of once per year.
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure (FIM)
Intervention Appropriateness Measure (IAM)
Program Sustainability Assessment Tool (PSAT)
Through study completion, an average of once per year.

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Evidence-based Resources
1 of 2
TeACH System Resources
1 of 2
Active Control
Experimental Treatment

276 Total Participants · 2 Treatment Groups

Primary Treatment: TeACH System Resources · No Placebo Group · N/A

TeACH System Resources
Experimental Group · 1 Intervention: TeACH System Resources · Intervention Types: Behavioral
Evidence-based ResourcesNoIntervention Group · 1 Intervention: Evidence-based Resources · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: administered to primary care staff through study completion, an average of once per year.
Closest Location: Rush University Medical Center · Chicago, IL
Photo of rush university medical center 1Photo of rush university medical center 2Photo of rush university medical center 3
2011First Recorded Clinical Trial
1 TrialsResearching Mental Health
793 CompletedClinical Trials

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
377 Previous Clinical Trials
151,696 Total Patients Enrolled
1 Trials studying Mental Health
35 Patients Enrolled for Mental Health

Eligibility Criteria

Age < 18 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between 13 and 17 years of age.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.